From a functional point of view, AR seemed to promote tumor growth in glioma: an increase in cell death and an accumulation of cells in sub-G1 are observed when blocking the AR activity by specific inhibitors (bicalutamide or enzalutamide) or protein expression by siRNA in A172, U87 and T98G cells. The gene discussed is AR; the disease is neoplasm.